EXHIBIT 99.1 DTST Reports 2025 Second Quarter Financial Results and Provides Business Update Conference Call to be Held Today at 11:00 am ET MELVILLE, N.Y., August 14, 2025 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (the "Company"), today provided a business update and reported financial results for the three months and six months ended June 30, 2025. "In connection with the proposed transaction if approved by our shareholders and consummated, our Board of Directors has authorized a tender o ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Registrant's telephone number, including area code: (858) 550-1900 N/A (Former name or former address, if changed since last report.) Securities registered pursuant to Section 12(b) of the A ...

Exhibit 99.1 Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update — Increased Net Sales and Improved Loss from Operations in Q2 2025 vs. Prior Year Quarter — — Evofem Advances Plans for Special Meeting of Stockholders to Approve the A&R Merger Agreement and Become a Wholly-owned Subsidiary of Aditxt — SAN DIEGO, CA, August 14, 2025 — Women's health innovator Evofem Biosciences, Inc. (Evofem or the Company) (OTCID: EVFM), today announced financial results for the thr ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM _________ to __________ COMMISSION FILE NUMBER 001-41748 DeFi DEVELOPMENT CORP (Exact name of registrant as specified in its charter) | Delaware | 83-2676794 | ...

[Overview of Q3 FY2025 Performance](index=1&type=section&id=Overview%20of%20Q3%20FY2025%20Performance) CSPi reported strong Q3 FY2025 operational momentum with 20% TS revenue growth and new customer acquisitions, alongside an 18% increase in total revenue to $15.4 million, despite a net loss [Key Achievements and Operating Highlights](index=1&type=section&id=Key%20Achievements%20and%20Operating%20Highlights) CSPi reported significant operational momentum in Q3 FY2025, highlighted by a 20% revenue growth in the Technology Solutions (TS) segment. The company secured new customers for its AZT PROTECT™ offering in key industrial sectors and expanded its relationship with a South African client. These achievements, coupled with its inclusion in the Russell 3000® Index, are expected to enhance market awareness and drive future growth - Technology Solutions (TS) revenue grew **20% year-over-year**, driven by demand for cloud-based services and from maritime customers[4](index=4&type=chunk) - The company is experiencing strong momentum with its AZT PROTECT™ offering, signing new customers in the steel, concrete, and lumber industries through its reseller and distribution strategy[3](index=3&type=chunk)[4](index=4&type=chunk) - Internationally, the High-Performance Products (HPP) segment secured a follow-up, multi-year contract with a South African cell tower company to deploy AZT PROTECT™[3](index=3&type=chunk)[4](index=4&type=chunk) - The company was added to the Russell 3000® Index, which is anticipated to increase awareness among institutional investors[3](index=3&type=chunk)[4](index=4&type=chunk) - The Board of Directors declared a quarterly dividend of **$0.03 per share**[1](index=1&type=chunk)[4](index=4&type=chunk) [Financial Performance Summary](index=1&type=section&id=Financial%20Performance%20Summary) For the third quarter of fiscal 2025, CSPi's total revenue increased by 18% year-over-year to $15.4 million, primarily driven by a 29% rise in product revenue. However, gross margin declined from 34% to 29% due to the revenue mix, resulting in a net loss of $0.3 million, or $0.03 per share. For the nine-month period, revenue grew to $44.3 million, but net income fell sharply to $0.1 million from $1.3 million in the prior year. The company maintained a strong balance sheet with $26.3 million in cash and equivalents Q3 FY2025 vs Q3 FY2024 Financial Results (in millions) | Metric | Q3 FY2025 | Q3 FY2024 | Change | | :--- | :--- | :--- | :--- | | Total Revenue | $15.4 | $13.1 | +18% | | Product Revenue | $10.2 | $7.8 | +29% | | Service Revenue | $5.3 | $5.3 | Flat | | Gross Profit | $4.5 | $4.6 | -2.2% | | Gross Margin | 29% | 34% | -5 p.p. | | Net Loss | $(0.3) | $(0.2) | Increased Loss | | Diluted EPS | $(0.03) | $(0.02) | Increased Loss | Nine Months FY2025 vs FY2024 Financial Results (in millions) | Metric | Nine Months FY2025 | Nine Months FY2024 | Change | | :--- | :--- | :--- | :--- | | Total Revenue | $44.3 | $42.2 | +5.0% | | Gross Profit | $13.2 | $15.2 | -13.2% | | Gross Margin | 30% | 36% | -6 p.p. | | Net Income | $0.1 | $1.3 | -92.3% | | Diluted EPS | $0.01 | $0.13 | -92.3% | - The company maintained a robust balance sheet with **$26.3 million** in cash and cash equivalents as of June 30, 2025[7](index=7&type=chunk) - During the quarter, the company repurchased over **19,000 shares** for a total cost of **$0.3 million**, with approximately **0.3 million shares** remaining under the current repurchase authorization[7](index=7&type=chunk) [Detailed Financial Statements](index=6&type=section&id=Detailed%20Financial%20Statements) This section provides a detailed breakdown of CSPi's financial position and performance, showing a decrease in total assets and cash, alongside a widened operating loss and significant drop in nine-month net income [Condensed Unaudited Consolidated Balance Sheets](index=6&type=section&id=Condensed%20Unaudited%20Consolidated%20Balance%20Sheets) As of June 30, 2025, CSPi's total assets were $66.8 million, a decrease from $69.4 million at the end of fiscal year 2024. The decline was primarily driven by a reduction in cash and cash equivalents from $30.6 million to $26.3 million. Total liabilities also decreased to $19.3 million from $22.2 million, while shareholders' equity remained stable at $47.5 million Balance Sheet Summary (in thousands) | Account | June 30, 2025 | September 30, 2024 | | :--- | :--- | :--- | | Cash and cash equivalents | $26,308 | $30,585 | | Total current assets | $49,504 | $54,849 | | Total assets | $66,784 | $69,436 | | Total current liabilities | $15,366 | $18,682 | | Total liabilities | $19,300 | $22,166 | | Shareholders' equity | $47,484 | $47,270 | [Condensed Unaudited Consolidated Statements of Operations](index=7&type=section&id=Condensed%20Unaudited%20Consolidated%20Statements%20of%20Operations) The statement of operations for Q3 2025 shows a year-over-year revenue increase to $15.4 million, but a decline in gross profit to $4.5 million. Operating expenses rose to $5.7 million, widening the operating loss to $(1.2) million from $(0.7) million in the prior-year quarter. The net loss attributable to common shareholders was $(264) thousand. For the nine-month period, net income dropped significantly to $94 thousand from $1.24 million a year earlier Statement of Operations - Three Months Ended June 30 (in thousands) | Metric | 2025 | 2024 | | :--- | :--- | :--- | | Total sales | $15,448 | $13,105 | | Gross profit | $4,453 | $4,582 | | Operating (loss) income | $(1,223) | $(720) | | Net (loss) income | $(264) | $(185) | Statement of Operations - Nine Months Ended June 30 (in thousands) | Metric | 2025 | 2024 | | :--- | :--- | :--- | | Total sales | $44,265 | $42,186 | | Gross profit | $13,224 | $15,155 | | Operating (loss) income | $(2,571) | $171 | | Net income | $100 | $1,330 | [Corporate Information and Outlook](index=3&type=section&id=Corporate%20Information%20and%20Outlook) This section provides an overview of CSPi's business segments, details for the upcoming financial results conference call, and a cautionary statement regarding forward-looking projections [About CSPi](index=3&type=section&id=About%20CSPi) CSPi operates through two distinct segments. The High Performance Product segment, featuring ARIA Cybersecurity Solutions, focuses on protecting critical assets with solutions like AZT for application shielding and ARIA ADR for threat detection. The Technology Solutions segment provides innovative IT solutions, professional services, and managed IT services across key technology areas like security, data center, and networking, by partnering with leading technology providers - The High Performance Product segment (ARIA Cybersecurity) provides solutions to shield critical applications (AZT solution), monitor internal traffic for threat detection (ARIA ADR), and interrogate network packets (AZT Gateway Software)[10](index=10&type=chunk) - The Technology Solutions segment offers managed IT services (24x365 proactive support) and professional services in five key areas: Advanced Security, Communication, Data Center, Networking, and Wireless & Mobility[11](index=11&type=chunk) [Conference Call Information](index=3&type=section&id=Conference%20Call%20Information) CSPi management, including CEO Victor Dellovo and CFO Gary W. Levine, will host a conference call to discuss the financial results and provide a business update. The call is scheduled for 10:00 a.m. (ET) on the day of the release - A conference call with CEO Victor Dellovo and CFO Gary W. Levine is scheduled for **10:00 a.m. (ET)** to review financial results. A live webcast and telephone dial-in options are available[9](index=9&type=chunk) [Forward-Looking Statements (Safe Harbor)](index=5&type=section&id=Forward-Looking%20Statements%20%28Safe%20Harbor%29) The company has issued a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995. This statement cautions that forward-looking projections regarding business performance, revenue, and strategic actions are subject to risks and uncertainties. Actual results may differ materially due to economic, market, and competitive factors as detailed in the company's SEC filings - The company's forward-looking statements include expectations of growing top and bottom lines for the full fiscal year and leveraging its Russell 3000® Index inclusion to attract new customers and investors[12](index=12&type=chunk) - The company warns that actual results could differ materially from these statements due to various risks, including general economic conditions, market factors, and competitive pressures[13](index=13&type=chunk)

In April, Clene presented new evidence of remyelination and neuronal repair with CNM-Au8 treatment at the American Academy of Neurology (AAN) Late-Breaking Science Session at the AAN 2025 Annual Meeting. The presentation, titled "Physiologic and Anatomical Evidence of Neuronal Repair and Remyelination from the Long-Term Open-Label Extension of the Phase 2 VISIONARY-MS Trial," highlighted significant and clinically meaningful improvements in cognition and visual function, supported by corresponding objective ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 14, 2025 (Address of principal executive offices and zip code) (804) 487-8196 (Registrant's telephone number including area code) N/A (Former name or former address, if changed since last report) Adial Pharmaceuticals, Inc. (Exact name of registrant as specified in charter) | Delaware | ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2025 For the transition period from ________ to ________ Commission File Number: 001-40439 NeuroOne Medical Technologies Corporation (Exact name of Registrant as specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) 7599 Anagram Drive Eden Prairie, MN 5534 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 14, 2025 Toppoint Holdings Inc. | (Exact name of registrant as specified in its charter) | | | | --- | --- | --- | | Nevada | 001-42471 | 92-2375560 | | (State or other jurisdiction | (Commission File Number) | (IRS Employer | | of incorporation) | | Identification No.) | | 1250 Kenas Roa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File No. 001-39885 VERSUS SYSTEMS INC. (Exact name of registrant as specified in its charter) | Delaware | 45-4542599 | | --- ...